Boryung to foster Astrix for a public healthcare drug

Boryung has adopted a marketing strategy for "Astrix" (a drug for thrombosis) to be fostered as a public healthcare remedy. Astrix is a 100mg low dosed aspirin preparation for the prevention of cardiovascular disorders with an excellent safety profile for a long term administration, currently marking its top position in its therapeutic field.

It contains aspirin in an enteric coated pellet...